Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Medicago receives $3.8M as second milestone payment from U.S. DARPA for cGMP vaccine facility

Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced it has received the second milestone payment of US$3.8 million from the Defense Advanced Research Projects Agency ("DARPA").

15 Mar 2011

ShangPharma fourth quarter net revenues increase 29.4% to $25.6 million

ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced its financial results for its fourth quarter and the fiscal year ended December 31, 2010.

15 Mar 2011

Indium oxine in development at Positron's Crown Point facility

Positron Corporation a molecular imaging company announced today that it is developing indium oxine, a radiopharmaceutical widely used for the radiolabeling of blood elements. This project signifies Positron's entrance into direct radiopharmaceutical manufacturing and sales; indium oxine is the first new product in development at Positron's research, development and manufacturing facility in Crown Point, Indiana.

14 Mar 2011

Daylight Solutions ships its 200th commercial laser system for scientific applications

Daylight Solutions, Inc., a leading manufacturer of advanced molecular detection, spectroscopic imaging, and high-power illumination solutions, shipped its 200th commercial laser system for scientific applications at the close of 2010.

From Daylight Solutions Inc 14 Mar 2011

ChromaDex pTeroPure Pterostilbene receives 2010 Most Promising Ingredient of the Year award

ChromaDex Corporation, announced today that the Company has been awarded the 2010 North American Health Ingredients Most Promising Ingredient of the Year award by the independent research company, Frost & Sullivan, for its proprietary branded ingredient pTeroPure™ Pterostilbene.

11 Mar 2011

Halozyme Therapeutics 2010 net loss decreases to $53.2 million

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the fourth quarter and year ended December 31, 2010.

11 Mar 2011

Sonitus Medical's SoundBite Hearing System receives CE Mark certification

Sonitus Medical, Inc., a medical device company that manufactures the world's first non-surgical and removable hearing prosthetic to transmit sound via the teeth, today announced that it has received CE Mark certification for its SoundBite Hearing System. The company has received its EC Certificate, which indicates Full Quality Assurance System Approval. This is the first European regulatory certification for the company and the product.

11 Mar 2011

FDA announces consent decree of permanent injunction against McNeil-PPC

The U.S. Food and Drug Administration announced today that a consent decree of permanent injunction has been filed against McNeil-PPC and two of its officers for failing to comply with current good manufacturing practice requirements as required by federal law.

11 Mar 2011

FDA holds Senesco's SNS01-T clinical study due to delay of supplier's DMF updation

Senesco Technologies, Inc., announced today that the U.S. Food and Drug Administration has informed the Company that its planned study in multiple myeloma is on hold until the Drug Master File of one of its suppliers is updated.

11 Mar 2011

Harvard, Oxford Nanopore enter exclusive agreement for graphene DNA sequencing

Oxford Nanopore Technologies Ltd today announced an exclusive agreement with Harvard University's Office of Technology Development for the development of graphene for DNA sequencing.

From Oxford Nanopore Technologies 11 Mar 2011

FDA approves Matrix NDA for Zidovudine Tablets

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration under the President's Emergency Plan for AIDS Relief for its New Drug Application for Zidovudine Tablets, 100 mg.

10 Mar 2011

FDA approves Covidien's LEU-based Mo-99 medical isotope

Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration has approved the use of molybdenum-99 derived from low-enriched uranium (LEU) in the production of technetium-99m generators.

10 Mar 2011

Oncothyreon 2010 net loss decreases to 15.6 million

Oncothyreon Inc. today reported financial results for the year and quarter ending December 31, 2010.

10 Mar 2011

Medtronic resolves FDA warning letters over Mounds View, Juncos facilities

Medtronic, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the company that issues noted in two warning letters -- one from November 2009 regarding the company's Mounds View, Minnesota facility and another from June 2009 regarding the company's manufacturing facility in Juncos, Puerto Rico -- have been resolved.

10 Mar 2011

Medtronic opens new manufacturing facility in Singapore

Medtronic, Inc., the global medical technology leader, announced today the official opening of its new manufacturing facility, Medtronic Singapore Operations. The facility will enhance the company's manufacturing capabilities to meet the future expected growth of cardiac devices in Asia.

10 Mar 2011

Israel grants patent to Kamada's Transferrin for use in Pharmaceutical Compositions

Kamada, a biopharmaceutical company developing, manufacturing and marketing specialty life-saving therapeutics, announced today it has received an Israeli Patent for its Ultrapure Transferrin to be used in Pharmaceutical Compositions.

10 Mar 2011

Adamis submits APC-100 IND to FDA for treatment of prostate cancer

Adamis Pharmaceuticals Corporation announced today that it has recently submitted to the FDA an Investigational New Drug application for APC-100 to treat prostate cancer.

9 Mar 2011

Also in global health news: Rights abuses in Myanmar; Indian malnutrition; Mali Global Fund grant; shift in USAID's programs in Afghanistan; Gates Foundation grant for vaccines

Human Rights Abuses Impacting Health Situation In Parts Of Myanmar, Study Says.

9 Mar 2011

Patrys succeeds in obtaining commercial yields for its anti-cancer antibody therapeutic

Patrys Limited (ASX: PAB), which is developing a new class of antibody molecules for the treatment of cancer, is pleased to announce success in obtaining commercial production yields for natural human antibody PAT-SC1, facilitating the advancement of this promising product toward a second human clinical trial for the treatment of cancer.

8 Mar 2011

Conflicts in medical management of hemophilia

Hemophilia is a medical disorder that is part of our genetic load as humans. It will never disappear. Therefore, the only way to live with it is to receive adequate medical management. Its effects on those males who have inherited the disorder that affects their blood clotting without treatment includes recurrent hemorrhages (bleeds) into joints as well as internal bleeding. The bleeds are painful, resulting in disuse, disability and crippling. The first signs usually appear in early childhood. A child who suffers a mouth bleed can slowly lose enough blood to result in death.

8 Mar 2011

Manufacturing News and Research

Further Reading

Medicago receives $3.8M as second milestone payment from U.S. DARPA for cGMP vaccine facility

ShangPharma fourth quarter net revenues increase 29.4% to $25.6 million

Indium oxine in development at Positron's Crown Point facility

Daylight Solutions ships its 200th commercial laser system for scientific applications

ChromaDex pTeroPure Pterostilbene receives 2010 Most Promising Ingredient of the Year award

Halozyme Therapeutics 2010 net loss decreases to $53.2 million

Sonitus Medical's SoundBite Hearing System receives CE Mark certification

FDA announces consent decree of permanent injunction against McNeil-PPC

FDA holds Senesco's SNS01-T clinical study due to delay of supplier's DMF updation

Harvard, Oxford Nanopore enter exclusive agreement for graphene DNA sequencing

FDA approves Matrix NDA for Zidovudine Tablets

FDA approves Covidien's LEU-based Mo-99 medical isotope

Oncothyreon 2010 net loss decreases to 15.6 million

Medtronic resolves FDA warning letters over Mounds View, Juncos facilities

Medtronic opens new manufacturing facility in Singapore

Israel grants patent to Kamada's Transferrin for use in Pharmaceutical Compositions

Adamis submits APC-100 IND to FDA for treatment of prostate cancer

Also in global health news: Rights abuses in Myanmar; Indian malnutrition; Mali Global Fund grant; shift in USAID's programs in Afghanistan; Gates Foundation grant for vaccines

Patrys succeeds in obtaining commercial yields for its anti-cancer antibody therapeutic

Conflicts in medical management of hemophilia

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy